У нас вы можете посмотреть бесплатно Chasity has been living with stage 4 lung cancer since 2018- Patient Conversations with Leah или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
🌟 New Episode Alert! 🌟 Join us for another inspiring and heartfelt conversation in the second episode of the YLCI Podcast: Patient Conversations with Leah. Hosted by Leah Phillips, lung cancer patient and co-founder of the Young Lung Cancer Initiative, alongside Chasity Harney, a lung cancer patient diagnosed in 2018, this episode dives deep into the realities of living with young lung cancer. In this candid discussion, Leah and Chasity share their personal experiences, touching on Chasity's diagnosis story, the invaluable support from other patient advocates, and navigating family life while managing treatment. They also explore the power of hope and the strength required to face life with a lung cancer diagnosis. Whether you're a patient, caregiver, advocate, or just seeking to understand more about young lung cancer, this episode offers valuable insights into the emotional and practical aspects of life with this diagnosis. Disclaimer: The information shared in this podcast is for informational and educational purposes only and is based on the personal experiences of the guests. It is not intended as medical advice or as a substitute for professional medical guidance, diagnosis, or treatment. Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition. The views and opinions expressed by the guests are their own and do not necessarily reflect the views of the podcast or its sponsors. #egfr #lungcancer #cancerstory #cancerwarrior #chemotherapy #tagrisso #osimertinib